SCHEMBL6168733

SCHEMBL6168733

[c]1cccnc1CN1CCOCC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 1/20 0.45
ALDH1A1 P00352 2/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
CYP2A13 Q16696 7/20 0.40
HTT P42858 1/20 0.40
HRH3 Q9Y5N1 1/20 0.40
METAP2 P50579 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
PAX8 Q06710 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
HSD17B10 Q99714 2/20 0.39
CYP2C9 P11712 1/20 0.39
ALOX15 P16050 1/20 0.39
KDM4E B2RXH2 1/20 0.38
GLA P06280 1/20 0.38
GAA P10253 1/20 0.38
HPGD P15428 1/20 0.38
NCF1 P14598 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL948263 0.84 POLB (0.41) MEN1KMT2AHTTNPC1RAB9A
SCHEMBL6167679 0.80 SIGMAR1 (0.43) CXCR4ALDH1A1MEN1KMT2AHRH3
SCHEMBL6163912 0.80 CYP2A13 (0.39) ALDH1A1MEN1KMT2ACYP2A13NPC1
SCHEMBL6270109 0.74 CXCR4 (0.53) CXCR4ALDH1A1MEN1KMT2ACYP2A13
SCHEMBL3730344 0.71 CXCR4 (0.46) CXCR4ALDH1A1MEN1KMT2ACYP2A13
SCHEMBL935029 0.71 L3MBTL1 (0.48) ALDH1A1MEN1KMT2AHTTNPC1
SCHEMBL353955 0.70 POLB (0.41) ALDH1A1HTTCYP2C9KDM4E
SCHEMBL1077472 0.70 ALDH1A1 (0.36) ALDH1A1MEN1KMT2AHRH3L3MBTL1
SCHEMBL994388 0.69 GRM4 (0.39) ALDH1A1HRH3HSD17B10KDM4EGAA
SCHEMBL948461 0.69 KDM4E (0.48) ALDH1A1MEN1KMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1417177-A4 ACYLSEMICARBAZIDES AS CYCLIN DEPENDENT KINASE INHIBITORS USEFUL AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS BRISTOL MYERS SQUIBB PHARMA CO (US) 2005-10-19 EP disclosed
EP-1417177-A2 ACYLSEMICARBAZIDES AS CYCLIN DEPENDENT KINASE INHIBITORS USEFUL AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS Bristol-Myers Squibb Pharma Company (US) 2004-05-12 EP disclosed
WO-2003007883-A2 ACYLSEMICARBAZIDES AS CYCLIN DEPENDENT KINASE INHIBITORS USEFUL AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2003-01-30 WO disclosed
EP-1071668-A1 5-AMINOINDENO(1,2-C)PYRAZOL-4-ONES AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS Du Pont Pharmaceuticals Company (US) 2001-01-31 EP disclosed
WO-1999054308-A1 5-AMINOINDENO(1,2-C)PYRAZOL-4-ONES AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS DU PONT PHARMACEUTICALS COMPANY (US) 1999-10-28 WO disclosed